A Journey in Support of Diversity
Since he was young, Sergio Armani has always found solace on the bike, spending many childhood days riding 20 miles
Since he was young, Sergio Armani has always found solace on the bike, spending many childhood days riding 20 miles
At Advarra, we are passionate about enabling the industry to become more site-centric. To achieve this, it is especially important
Understanding clinical trial billing rules, from Medicare policies to state laws, is crucial for avoiding compliance pitfalls and supporting trial integrity.
Central and local IRBs share the same research oversight goals, but NIH’s single IRB mandate challenges local IRBs to adapt their broader responsibilities.
As clinical research sites face more challenges than perhaps ever before, it’s increasingly important to provide sites with proper support
In clinical research, institutional review boards (IRBs) a vital role in ensuring participant rights and ethical standards are upheld throughout the trial.
For the past two years, the clinical research industry has seen an acceleration in staff shifting to a remote, work
In medical device research, the determination of “significant risk” or “nonsignificant risk” is sometimes confusing, especially for those new to
The most recent Cancer Center Support Grant (CCSG) guidelines released by the National Cancer Institute (NCI) include a new Core
The Food and Drug Administration (FDA) is a U.S. public health authority within the Department of Health and Human Services
With diversity, equity, and inclusion efforts currently at the forefront of the research community’s collective mind, we’re also seeing increased
Sites gain control with Advarra’s BYOT approach, eliminating redundant tasks and fostering efficient collaboration between research stakeholders and participants.